122 related articles for article (PubMed ID: 19089925)
1. Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis.
Gaudet MM; Hunter K; Pharoah P; Dunning AM; Driver K; Lissowska J; Sherman M; Peplonska B; Brinton LA; Chanock S; Garcia-Closas M
Int J Cancer; 2009 Apr; 124(7):1716-20. PubMed ID: 19089925
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.
Hsieh SM; Smith RA; Lintell NA; Hunter KW; Griffiths LR
BMC Cancer; 2009 Sep; 9():331. PubMed ID: 19765277
[TBL] [Abstract][Full Text] [Related]
3. Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival.
Roberts MR; Hong CC; Edge SB; Yao S; Bshara W; Higgins MJ; Freudenheim JL; Ambrosone CB
Breast Cancer Res Treat; 2013 Jun; 139(3):873-85. PubMed ID: 23771732
[TBL] [Abstract][Full Text] [Related]
4. The association of SIPA1 gene polymorphisms with breast cancer risk: evidence from published studies.
Yi SM; Li GY
Tumour Biol; 2014 Jan; 35(1):441-5. PubMed ID: 24006220
[TBL] [Abstract][Full Text] [Related]
5. Association of SIPA1 545 C > T polymorphism with survival in Chinese women with metastatic breast cancer.
Pei R; Xu Y; Wei Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
Front Med; 2013 Mar; 7(1):138-42. PubMed ID: 23358895
[TBL] [Abstract][Full Text] [Related]
6. Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer.
Crawford NP; Ziogas A; Peel DJ; Hess J; Anton-Culver H; Hunter KW
Breast Cancer Res; 2006; 8(2):R16. PubMed ID: 16563182
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.
Brooks R; Kizer N; Nguyen L; Jaishuen A; Wanat K; Nugent E; Grigsby P; Allsworth JE; Rader JS
Gynecol Oncol; 2010 Mar; 116(3):539-43. PubMed ID: 19906411
[TBL] [Abstract][Full Text] [Related]
8. The contribution of SIPA1 and RRP1B germline polymorphisms to breast cancer phenotype, lymph node status and survival in a group of Lithuanian young breast cancer patients.
Ugenskienė R; Myrzaliyeva D; Jankauskaitė R; Gedminaitė J; Jančiauskienė R; Šepetauskienė E; Juozaitytė E
Biomarkers; 2016; 21(4):363-70. PubMed ID: 26901824
[TBL] [Abstract][Full Text] [Related]
9. Sipa1 promoter polymorphism predicts risk and metastasis of lung cancer in Chinese.
Xie C; Yang L; Yang X; Yang R; Li Y; Qiu F; Chen M; Fang W; Bin X; Deng J; Huang D; Liu B; Zhou Y; Lu J
Mol Carcinog; 2013 Nov; 52 Suppl 1():E110-7. PubMed ID: 23661532
[TBL] [Abstract][Full Text] [Related]
10. Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study.
Hsieh SM; Look MP; Sieuwerts AM; Foekens JA; Hunter KW
Breast Cancer Res; 2009; 11(5):R75. PubMed ID: 19825179
[TBL] [Abstract][Full Text] [Related]
11. The SIPA1 -313A>G polymorphism is associated with prognosis in inoperable non-small cell lung cancer.
Gdowicz-Kłosok A; Giglok M; Drosik A; Suwiński R; Butkiewicz D
Tumour Biol; 2015 Feb; 36(2):1273-8. PubMed ID: 25352027
[TBL] [Abstract][Full Text] [Related]
12. Expression of signal-induced proliferation-associated gene 1 (SIPA1), a RapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cells.
Ji K; Ye L; Toms AM; Hargest R; Martin TA; Ruge F; Ji J; Jiang WG
Cancer Genomics Proteomics; 2012; 9(5):321-7. PubMed ID: 22990111
[TBL] [Abstract][Full Text] [Related]
13. A novel nuclear localization region in SIPA1 determines protein nuclear distribution and epirubicin-sensitivity of breast cancer cells.
Ma Y; Weng J; Wang N; Zhang Y; Minato N; Su L
Int J Biol Macromol; 2021 Jun; 180():718-728. PubMed ID: 33753200
[TBL] [Abstract][Full Text] [Related]
14. Germline polymorphisms are potential metastasis risk and prognosis markers in breast cancer.
Hsieh SM; Lintell NA; Hunter KW
Breast Dis; 2006-2007; 26():157-62. PubMed ID: 17473374
[TBL] [Abstract][Full Text] [Related]
15. SIPA1 enhances SMAD2/3 expression to maintain stem cell features in breast cancer cells.
Wang N; Weng J; Xia J; Zhu Y; Chen Q; Hu D; Zhang X; Sun R; Feng J; Minato N; Gong Y; Su L
Stem Cell Res; 2020 Dec; 49():102099. PubMed ID: 33296812
[TBL] [Abstract][Full Text] [Related]
16. An insight into clinical outcome of XPG polymorphisms in breast cancer.
Malik SS; Mubarik S; Masood N; Khadim MT
Mol Biol Rep; 2018 Dec; 45(6):2369-2375. PubMed ID: 30255276
[TBL] [Abstract][Full Text] [Related]
17. KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes.
Hartikainen JM; Tengström M; Winqvist R; Jukkola-Vuorinen A; Pylkäs K; Kosma VM; Soini Y; Mannermaa A
Clin Cancer Res; 2015 Apr; 21(7):1591-601. PubMed ID: 25589623
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in five genes important in telomere biology and risk for breast cancer.
Savage SA; Chanock SJ; Lissowska J; Brinton LA; Richesson D; Peplonska B; Bardin-Mikolajczak A; Zatonski W; Szeszenia-Dabrowska N; Garcia-Closas M
Br J Cancer; 2007 Sep; 97(6):832-6. PubMed ID: 17848914
[TBL] [Abstract][Full Text] [Related]
19. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.
Udler M; Maia AT; Cebrian A; Brown C; Greenberg D; Shah M; Caldas C; Dunning A; Easton D; Ponder B; Pharoah P
J Clin Oncol; 2007 Jul; 25(21):3015-23. PubMed ID: 17634480
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in EBV reactivation-related genes and the risk and survival of breast cancer.
Zhang W; Zhang ZZ; Tang LY; Lin Y; Su FX; Xie XM; Su XF; Ren ZF
Tumour Biol; 2016 Jun; 37(6):8337-47. PubMed ID: 26729199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
